Shahrokh Shariat Selected Research

Biomarkers (Surrogate Marker)

11/2023	Examining the Relationship and Prognostic Significance of Cell-Free DNA Levels and the PSMA-Positive Tumor Volume in Men with Prostate Cancer: A Retrospective-Prospective [68Ga]Ga-PSMA-11 PET/CT Study.
1/2022	Comparative proteome analysis identified CD44 as a possible serum marker for docetaxel resistance in castration-resistant prostate cancer.
11/2021	Metastatic clear cell renal cell carcinoma: computed tomography texture analysis as predictive biomarkers of survival in patients treated with nivolumab.
2/2013	Assays for prostate cancer : changing the screening paradigm?
1/2005	BPSA: A Novel Serum Marker for Benign Prostatic Hyperplasia.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Shahrokh Shariat Research Topics

Disease

23	Prostatic Neoplasms (Prostate Cancer) 05/2024 - 01/2005
17	Neoplasms (Cancer) 05/2024 - 05/2004
7	Urinary Bladder Neoplasms (Bladder Cancer) 03/2022 - 02/2005
6	Carcinoma (Carcinomatosis) 01/2022 - 04/2011
5	Non-Muscle Invasive Bladder Neoplasms 10/2023 - 11/2016
4	Neoplasm Metastasis (Metastasis) 01/2021 - 04/2009
3	Renal Cell Carcinoma (Grawitz Tumor) 02/2022 - 01/2021
2	Extranodal Extension 12/2007 - 05/2004
1	Hemorrhage 03/2022
1	Urinary Calculi (Urinary Calculus) 11/2020
1	Thrombocytopenia (Thrombopenia) 03/2018
1	Anemia 03/2018
1	Lymphatic Metastasis 11/2016
1	Prostatic Hyperplasia (Benign Prostatic Hyperplasia) 01/2005

Drug/Important Bio-Agent (IBA)

7	Prostate-Specific Antigen (Semenogelase)IBA 08/2020 - 05/2004
6	AntigensIBA 05/2024 - 11/2016
5	Biomarkers (Surrogate Marker)IBA 11/2023 - 01/2005
4	LigandsIBA 05/2024 - 01/2020
4	Hormones (Hormone)IBA 05/2024 - 01/2018
2	AndrogensIBA 11/2023 - 01/2018
2	Proteins (Proteins, Gene)FDA Link 01/2023 - 07/2018
2	ThuliumIBA 03/2022 - 11/2020
2	Docetaxel (Taxotere)FDA Link 01/2022 - 01/2021
2	NivolumabIBA 11/2021 - 01/2021
2	177Lu-PSMA-617IBA 01/2021 - 01/2020
1	Circulating Tumor DNAIBA 05/2024
1	Cell-Free Nucleic AcidsIBA 11/2023
1	Antigen Receptors (Antigen Receptor)IBA 01/2023
1	Tyrosine Kinase InhibitorsIBA 02/2022
1	ProteomeIBA 01/2022
1	Concise-Cap-C-RyngeIBA 11/2021
1	enzalutamideIBA 01/2021
1	cabazitaxel FDA Link 01/2021
1	abirateroneIBA 01/2021
1	Guanosine Diphosphate (GDP)IBA 12/2020
1	gallium 68 PSMA-11IBA 08/2020
1	pembrolizumabIBA 04/2020
1	BCG ConnaughtIBA 11/2016
1	Choline (Choline Chloride)IBA 11/2016
1	Forkhead Transcription Factors (Forkhead Box Proteins)IBA 08/2016
1	Fatty Acid Synthases (Fatty Acid Synthase)IBA 11/2015
1	Acetates (Acetic Acid Esters)FDA Link 11/2015
1	A 7 (A-7)IBA 05/2015
1	Sex Hormone-Binding GlobulinIBA 04/2009
1	Finasteride (Propecia)FDA LinkGeneric 12/2007

Therapy/Procedure

13	Therapeutics 11/2023 - 01/2018
8	Prostatectomy (Retropubic Prostatectomy) 01/2023 - 05/2004
7	Lymph Node Excision (Lymph Node Dissection) 01/2023 - 04/2009
5	Castration 05/2024 - 03/2018
5	Nephroureterectomy 01/2022 - 04/2011
4	Radiotherapy 01/2017 - 09/2014
3	Cystectomy 01/2022 - 02/2005
2	Lasers (Laser) 03/2022 - 11/2020
2	Nephrectomy 01/2019 - 10/2018
1	Transurethral Resection of Bladder 10/2023
1	Electrocoagulation (Electrocautery) 03/2022
1	Transjugular Intrahepatic Portasystemic Shunt 12/2021
1	Immunotherapy 03/2019
1	Adjuvant Chemotherapy 10/2016
1	Adjuvant Radiotherapy 10/2016
1	Chemoprevention 12/2007
1	Urinary Diversion (Ileal Conduit) 02/2005